RegenPep
Growth Factor Research

IGF-1 Growth Factors: The Master Regulator

Insulin-like Growth Factor 1 (IGF-1) is a critical mediator of cellular proliferation, differentiation, and survival. Understanding its mechanism and variants—IGF-1 LR3 and IGF-1 DES—is essential for researchers studying tissue regeneration, metabolism, and the somatotropic axis.

What is Insulin-like Growth Factor 1?

Insulin-like Growth Factor 1 (IGF-1), also known as Somatomedin C, is a 70-amino acid polypeptide hormone structurally homologous to proinsulin. It is primarily synthesized in the liver in response to Growth Hormone (GH) stimulation, though many tissues produce IGF-1 locally through paracrine and autocrine mechanisms.

IGF-1 plays a pivotal role in the Growth Hormone/IGF-1 axis—the neuroendocrine system responsible for postnatal growth, tissue maintenance, and metabolic regulation. When GH is released from the anterior pituitary, it travels to the liver and stimulates IGF-1 secretion. IGF-1 then mediates many of GH’s anabolic and growth-promoting effects throughout the body.

At the molecular level, IGF-1 exerts its biological effects by binding to the IGF-1 Receptor (IGF-1R), a transmembrane receptor tyrosine kinase. This binding triggers receptor autophosphorylation and initiates two major intracellular signaling cascades: the PI3K/Akt pathway (promoting protein synthesis and cell survival) and the Ras/MAPK pathway (driving cell proliferation and differentiation).

The complexity of IGF-1 biology is further modulated by a family of six IGF Binding Proteins (IGFBPs) that regulate its bioavailability, extend its serum half-life, and facilitate tissue-specific delivery. This intricate regulatory network makes IGF-1 a fascinating subject for research across multiple disciplines.

70

Amino Acids

7.6 kDa

Molecular Weight

6

Binding Proteins

IGF-1 Signaling Cascade

Growth Hormone

Pituitary

IGF-1

Liver/Tissues

IGF-1 Receptor (IGF-1R)

Tyrosine Kinase Activation

PI3K/Akt

Protein Synthesis

Cell Survival

Ras/MAPK

Cell Proliferation

Differentiation

Simplified representation of the GH/IGF-1 axis and downstream signaling pathways.

Modified Variants

IGF-1 LR3 vs. IGF-1 DES: Understanding the Differences

Researchers have developed modified IGF-1 analogs to enhance specific properties. Each variant offers unique characteristics for different experimental applications.

Native IGF-1

The endogenous form of IGF-1 consisting of 70 amino acids. Native IGF-1 binds strongly to all six IGF Binding Proteins (IGFBPs), which sequester the majority of circulating IGF-1 and regulate its bioavailability. This results in a relatively short half-life in serum (~10-20 minutes for free IGF-1).

Length 70 amino acids
IGFBP Affinity High
Half-Life ~10-20 min (free)

IGF-1 LR3

Popular

Long R3 IGF-1 is an 83-amino acid analog featuring a 13-amino acid N-terminal extension peptide and an arginine substitution at position 3 (Glu→Arg). These modifications dramatically reduce binding affinity to IGFBPs, resulting in significantly higher bioactivity and extended half-life compared to native IGF-1.

Length 83 amino acids
IGFBP Affinity Very Low (~500x reduced)
Half-Life ~20-30 hours

IGF-1 DES

Potent

Des(1-3) IGF-1 is a truncated form of IGF-1 lacking the first three N-terminal amino acids (Gly-Pro-Glu). This naturally occurring variant was first isolated from brain tissue. The truncation eliminates virtually all IGFBP binding, resulting in exceptionally high potency at the IGF-1 receptor.

Length 67 amino acids
IGFBP Affinity Negligible
Potency ~10x native IGF-1

Molecular Mechanism of Action

A detailed look at how IGF-1 initiates cellular responses through receptor activation.

Step 1: Receptor Binding & Activation

IGF-1R Tyrosine Kinase Signaling

The IGF-1 Receptor (IGF-1R) is a heterotetrameric transmembrane receptor consisting of two extracellular α-subunits and two transmembrane β-subunits linked by disulfide bonds. The α-subunits contain the ligand-binding domain, while the β-subunits possess intrinsic tyrosine kinase activity.

When IGF-1 binds to the α-subunits, it induces a conformational change that activates the tyrosine kinase domains in the β-subunits. This triggers trans-autophosphorylation—each β-subunit phosphorylates tyrosine residues on the other. Key phosphorylation sites include Tyr1131, Tyr1135, and Tyr1136 in the kinase activation loop, which dramatically enhance enzymatic activity.

Step 2: PI3K/Akt Pathway Activation

Cell Survival & Protein Synthesis

The activated IGF-1R recruits and phosphorylates Insulin Receptor Substrate (IRS) proteins, primarily IRS-1 and IRS-2. Phosphorylated IRS proteins serve as docking sites for Src Homology 2 (SH2) domain-containing proteins, including the p85 regulatory subunit of Phosphoinositide 3-Kinase (PI3K).

PI3K activation generates phosphatidylinositol-3,4,5-trisphosphate (PIP3), which recruits Akt (Protein Kinase B) to the plasma membrane. Akt is then activated by phosphorylation at Thr308 (by PDK1) and Ser473 (by mTORC2). Active Akt phosphorylates numerous downstream targets:

  • mTORC1: Stimulates protein synthesis via S6K1 and 4E-BP1 phosphorylation
  • BAD/Bcl-2: Inhibits pro-apoptotic factors, promoting cell survival
  • FOXO transcription factors: Nuclear exclusion prevents apoptosis gene expression
  • GSK-3β: Inhibition promotes glycogen synthesis and cell cycle progression

Step 3: Ras/MAPK Pathway Activation

Cell Proliferation & Differentiation

In parallel to the PI3K pathway, IGF-1R activation also stimulates the Mitogen-Activated Protein Kinase (MAPK) cascade. Phosphorylated IRS proteins recruit the adaptor protein Grb2, which binds the guanine nucleotide exchange factor SOS. This complex activates the small GTPase Ras by promoting GDP-to-GTP exchange.

Active Ras-GTP initiates a phosphorylation cascade: Raf → MEK1/2 → ERK1/2. Activated ERK (Extracellular Signal-Regulated Kinase) translocates to the nucleus where it phosphorylates transcription factors including Elk-1, c-Fos, and c-Myc. These transcription factors drive expression of genes involved in cell cycle progression (Cyclin D1), differentiation, and mitogenesis.

The balance between PI3K/Akt and MAPK pathway activation determines cellular outcomes—whether a cell primarily increases protein synthesis, proliferates, differentiates, or survives apoptotic stimuli. This makes IGF-1 signaling contextually dependent on cell type and microenvironment.

Scientific Reference Context

For detailed molecular biology context, we recommend reviewing established scientific literature on growth factor signaling cascades.

IGF-1 Overview PI3K/Akt Pathway

Research Applications

IGF-1 peptides are utilized across multiple research domains due to their central role in growth and metabolism.

Muscle Hypertrophy Research

IGF-1 is essential for muscle protein synthesis via mTORC1 activation. Researchers study its role in satellite cell proliferation, myoblast differentiation, and muscle fiber hypertrophy. IGF-1 LR3 is particularly useful due to its extended half-life in culture media.

Neuronal Studies

IGF-1 promotes neuronal survival, axonal growth, and myelination. It is investigated for neuroprotective effects in models of neurodegenerative disease, traumatic brain injury, and age-related cognitive decline. IGF-1 DES shows enhanced activity in neural tissue.

Cell Proliferation Assays

As a potent mitogen, IGF-1 is used to stimulate cell proliferation in serum-free or low-serum culture conditions. It maintains cell viability while allowing researchers to study specific pathways without the confounding variables present in complete serum.

Metabolic Research

IGF-1 influences glucose uptake, lipid metabolism, and insulin sensitivity through partial activation of the insulin receptor. Studies examine the GH/IGF-1 axis in obesity, diabetes, and metabolic syndrome models.

Aging & Longevity

The GH/IGF-1 axis is a central node in aging biology. Paradoxically, reduced IGF-1 signaling extends lifespan in multiple model organisms, while local IGF-1 is important for tissue maintenance. This dichotomy drives active investigation.

Wound Healing Models

IGF-1 stimulates fibroblast proliferation, collagen synthesis, and keratinocyte migration—all critical for wound repair. In-vitro scratch assays and ex-vivo tissue models utilize IGF-1 to study regenerative mechanisms.

IGF-1 Research Glossary

Key terminology for understanding IGF-1 biology and experimental applications.

Somatomedin

Historical term for IGF-1 (Somatomedin C) and related factors. Named because they “mediate” the effects of “somatotropin” (Growth Hormone). The term reflects IGF-1’s role as the primary effector of GH action.

IGF Binding Proteins (IGFBPs)

A family of six proteins (IGFBP-1 through IGFBP-6) that bind IGF-1 with high affinity. They regulate bioavailability, extend half-life, and modulate IGF-1R binding. IGFBP-3 carries ~75% of circulating IGF-1.

Acid-Labile Subunit (ALS)

A liver-derived glycoprotein that forms a ternary complex with IGF-1 and IGFBP-3. This 150 kDa complex dramatically extends IGF-1 half-life to ~16 hours by preventing renal filtration.

Autocrine/Paracrine Signaling

Local IGF-1 production by many tissues (muscle, bone, brain) allows self-stimulation (autocrine) or stimulation of neighboring cells (paracrine), independent of hepatic/endocrine IGF-1 production.

Receptor Tyrosine Kinase (RTK)

A class of cell surface receptors with intrinsic kinase activity. The IGF-1R is an RTK that phosphorylates tyrosine residues on itself and downstream substrates upon ligand binding.

Hybrid Receptors

Receptors composed of one IGF-1R αβ half and one Insulin Receptor αβ half. These hybrids bind IGF-1 with higher affinity than insulin, complicating the separation of IGF-1 and insulin signaling effects.

Frequently Asked Questions

What is the difference between IGF-1, IGF-1 LR3, and IGF-1 DES?
Native IGF-1 is the endogenous 70-amino acid hormone that binds strongly to IGF Binding Proteins. IGF-1 LR3 (Long R3) is an 83-amino acid analog with a 13 AA extension and Arg substitution at position 3, which reduces IGFBP binding by ~500-fold and extends half-life to 20-30 hours. IGF-1 DES (Des 1-3) is a truncated 67 AA form missing the first three amino acids, resulting in negligible IGFBP binding and approximately 10x higher potency at the receptor. Choice depends on experimental goals: LR3 for sustained exposure, DES for acute high-potency studies.
How does IGF-1 promote cell proliferation and protein synthesis?
IGF-1 binds to the IGF-1 receptor (IGF-1R), a receptor tyrosine kinase. This triggers autophosphorylation and recruitment of IRS proteins, which activate two major cascades: (1) The PI3K/Akt/mTOR pathway promotes protein synthesis through S6K1 and 4E-BP1 phosphorylation, and prevents apoptosis by inhibiting FOXO transcription factors and pro-apoptotic proteins like BAD. (2) The Ras/MAPK/ERK pathway drives cell proliferation by activating transcription factors (Elk-1, c-Fos, c-Myc) that induce Cyclin D1 expression and cell cycle progression.
What role do IGF Binding Proteins play in IGF-1 biology?
IGFBPs are a family of six proteins that bind IGF-1 with affinity equal to or greater than the IGF-1 receptor. They serve multiple functions: (1) Extending half-life—free IGF-1 has a half-life of ~10-20 minutes, while IGFBP-bound IGF-1 (especially in the ternary complex with ALS) persists for ~16 hours. (2) Regulating bioavailability—IGFBPs sequester IGF-1, preventing receptor binding until proteases (like PAPP-A) cleave the binding protein. (3) Tissue targeting—different IGFBPs localize to different tissues, facilitating specific delivery. (4) IGF-independent effects—some IGFBPs have intrinsic signaling activities separate from IGF-1.
Which IGF-1 variant should I use for my cell culture experiments?
The choice depends on your experimental design. IGF-1 LR3 is most commonly used in cell culture because its reduced IGFBP binding means it remains active in media containing serum (which contains IGFBPs). Its extended half-life also means less frequent media changes. IGF-1 DES is ideal when you need maximum potency or are working in serum-free conditions where IGFBP interference is not a concern. Native IGF-1 is preferred when you need physiologically relevant IGFBP interactions or are co-studying IGFBP biology.
How should I reconstitute and store IGF-1 peptides?
Lyophilized IGF-1 peptides should be stored at -20°C (or -80°C for long-term). For reconstitution, use sterile acidified water (0.1M acetic acid or 10mM HCl) to a stock concentration of 0.1-1 mg/mL. IGF-1 is more stable at mildly acidic pH. Add solvent slowly down the vial wall and gently swirl—do not vortex. Aliquot reconstituted peptide to avoid freeze-thaw cycles. Once reconstituted, store at 4°C for up to 2-4 weeks or at -20°C for longer. For cell culture, dilute into PBS or culture media immediately before use.
What is the relationship between GH and IGF-1?
Growth Hormone (GH, somatotropin) and IGF-1 form a neuroendocrine axis. GH is released from the anterior pituitary in pulses, primarily during sleep. It travels to the liver where it binds the GH receptor and stimulates transcription of the IGF-1 gene. Hepatic IGF-1 accounts for ~75% of circulating IGF-1 (endocrine). However, GH also stimulates local IGF-1 production in many tissues (autocrine/paracrine). IGF-1 then provides negative feedback to the hypothalamus and pituitary, suppressing GHRH and GH release. Many effects historically attributed to GH are actually mediated by IGF-1, though GH also has direct effects independent of IGF-1.

Explore Our IGF-1 Research Catalog

Access high-purity IGF-1 variants including IGF-1 LR3 and IGF-1 DES for your cell culture, tissue engineering, and metabolic research applications. Every batch verified by HPLC and Mass Spectrometry.

Browse Growth Factors Request COA Data

USA Based • ≥99% Purity • Research Use Only

Regenpep - Footer

Your Cart

Your cart is empty

Subtotal: $0.00
View Cart Checkout